Publication | Closed Access

An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice

VaccinationNanomedicineMucosal VaccinationVaccine DevelopmentOcular Mucosal AdministrationImmunologyTherapeutic VaccineVaccine DesignPolyvalent VaccineMedicineMucosal ChallengeHerpes Simplex Virus Vaccines